Horizon 2020 - Innovative medicines initiative (IMI) Call 20

Research and Transfer Service

Submission deadline: 12 May 2020

Submission deadline for stage one: 12 May 2020 (first-stage proposals)

Call 20 of IMI have been launched and include the following topics:

  • Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in Psoriatic Arthritis
  • Innovations to accelerate vaccine development and manufacture
  • Real-world clinical implementation of liquid biopsy
  • Tumour plasticity
  • Proton versus photon therapy for oesophageal cancer – a trimodality strategy
  • Handling of protein drug products and stability concerns
  • Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
    Note: This topic is part of the IMI Antimicrobial Resistance (AMR) Accelerator programme

For further information, please visit the call webpage and contact Ms. Martina Pestoni.